Further qualitative and quantitative analyses revealed that RET immunoreactivity in nigral neurons in patients treated with direct nigral gene delivery were comparable to age-matched controls whereas patients treated with putamenal injections alone had RET staining similar to untreated Parkinson’s disease patients. The gene discussed is RET; the disease is Parkinson disease.